Efficacy, Safety, and Pharmacokinetics/Pharmacodynamic Study of L-Dopa/Carbidopa To Treat Parkinson's Disease
Phase 2
Completed
- Conditions
- Parkinson's Disease
- Interventions
- Drug: levodopa-carbidopa
- First Posted Date
- 2007-11-14
- Last Posted Date
- 2009-01-14
- Lead Sponsor
- Osmotica Pharmaceutical US LLC
- Target Recruit Count
- 78
- Registration Number
- NCT00558337
- Locations
- 🇦🇷
Fundación Rosarina de Neuro-Rehabilitación, Rosario, Argentina
🇦🇷Hospital San Bernardo, Salta, Argentina
🇦🇷Fundacion Alfredo Thomson, Buenos Aires, Argentina
© Copyright 2025. All Rights Reserved by MedPath